Recent News

Share
and/or
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
16 News Items found
Decoder
DNA wrapped around histones
What Is Epigenetics?

Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.
Finding
Pictured: Gabriela Chiosis
Hsp90: A Very Promising Target for Cancer Therapy

A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.
MSK at ASCO
Pictured: Jedd Wolchok
Memorial Sloan Kettering’s Expertise in Cancer Immunotherapy Draws Media Focus at 2014 ASCO Meeting

Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer.
In the Clinic
New Trial Advances Cell-Based Immune Therapy for Certain Leukemias

A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment.
In the Clinic
Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Memorial Sloan Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.
In the Clinic
Pictured: Isabelle Rivière and Michel Sadelain
Launch of Stem Cell Therapy Trial Offers Hope for Patients with Inherited Blood Disorder

Memorial Sloan Kettering’s trial to evaluate a new therapy for patients with beta-thalassemia is the first to receive FDA approval to treat this disease with genetically engineered cells.